Cargando…

The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers

The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This p...

Descripción completa

Detalles Bibliográficos
Autores principales: Donica, Vlad Constantin, Alexa, Anisia Iuliana, Pavel, Irina Andreea, Danielescu, Ciprian, Ciapă, Manuela Andreea, Donica, Alexandra Lori, Bogdănici, Camelia Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669604/
https://www.ncbi.nlm.nih.gov/pubmed/38002031
http://dx.doi.org/10.3390/biomedicines11113031
_version_ 1785139735476305920
author Donica, Vlad Constantin
Alexa, Anisia Iuliana
Pavel, Irina Andreea
Danielescu, Ciprian
Ciapă, Manuela Andreea
Donica, Alexandra Lori
Bogdănici, Camelia Margareta
author_facet Donica, Vlad Constantin
Alexa, Anisia Iuliana
Pavel, Irina Andreea
Danielescu, Ciprian
Ciapă, Manuela Andreea
Donica, Alexandra Lori
Bogdănici, Camelia Margareta
author_sort Donica, Vlad Constantin
collection PubMed
description The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS).
format Online
Article
Text
id pubmed-10669604
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106696042023-11-11 The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers Donica, Vlad Constantin Alexa, Anisia Iuliana Pavel, Irina Andreea Danielescu, Ciprian Ciapă, Manuela Andreea Donica, Alexandra Lori Bogdănici, Camelia Margareta Biomedicines Review The prevalence of multiple sclerosis (MS) has been increasing among young people in developing countries over the last years. With the continuous development of new technology, the diagnosis and follow-up of these patients has received new parameters that physicians may use in their practice. This paper reviews the main biomarkers identified through Optical Coherence Tomography Angiography (OCT-A) involved in the development and progression of MS and investigates the role it may have in detecting changes to the central nervous system (CNS). MDPI 2023-11-11 /pmc/articles/PMC10669604/ /pubmed/38002031 http://dx.doi.org/10.3390/biomedicines11113031 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Donica, Vlad Constantin
Alexa, Anisia Iuliana
Pavel, Irina Andreea
Danielescu, Ciprian
Ciapă, Manuela Andreea
Donica, Alexandra Lori
Bogdănici, Camelia Margareta
The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title_full The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title_fullStr The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title_full_unstemmed The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title_short The Evolvement of OCT and OCT-A in Identifying Multiple Sclerosis Biomarkers
title_sort evolvement of oct and oct-a in identifying multiple sclerosis biomarkers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669604/
https://www.ncbi.nlm.nih.gov/pubmed/38002031
http://dx.doi.org/10.3390/biomedicines11113031
work_keys_str_mv AT donicavladconstantin theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT alexaanisiaiuliana theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT pavelirinaandreea theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT danielescuciprian theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT ciapamanuelaandreea theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT donicaalexandralori theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT bogdanicicameliamargareta theevolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT donicavladconstantin evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT alexaanisiaiuliana evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT pavelirinaandreea evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT danielescuciprian evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT ciapamanuelaandreea evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT donicaalexandralori evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers
AT bogdanicicameliamargareta evolvementofoctandoctainidentifyingmultiplesclerosisbiomarkers